News and Media
The Amal lab combines advanced omics technologies with computational biology, biochemical, pharmacological and behavioral methods to discover novel drug targets and biomarkers in autism spectrum disorders and other neurological diseases.
Congratulations to Ms. Wajeha Hamoudi (PhD student from the Amal Lab), who was awarded The Best Talk presented in the The 35th Annual Meeting of the Israel Society for Oxygen and Free Radical Research (ISOFRR)
The National Institute for Psychobiology Awarded the First Prize for Doron Michaeli (the Amal Lab)
for the 2022 Poster competition
Ms. Shelly Ginzburg received JBC scholarship for undergraduates
The Amal Lab received the Nofar Grant from the Israeli Chief Scientist
Dr. Amal received the Grant of National Institute for Psychobiology in Israel
Ms. Maryam Kartawy received the prestigious Neubauer Family Foundation Ph.D Fellowship
Mr. Doron Michaeli won the Nano-Science and Nanotechnology Graduate Fellowship.
Dr. Haitham Amal has received the prestigious Prusiner-Abramsky Research Award in Clinical and Basic Neuroscience.
The Amal Lab received the HUJI – UK SPINE Seed fund, which will initiate a new collaboration with Oxford University
Ms. Shelly Ginzburg received the NanoMed Prize of the Nanomed and Nanotechnology Center of the Hebrew University.
Dr. Haitham Amal has received the Brettler Centre for Research in Molecular Pharmacology and Therapeutics Grant, 2020.
Dr. Haitham Amal has received the prestigious MAOF Fellowship for Excellent Young Scientist from the Council for Higher Education, 2020.
Dr. Haitham Amal received the prestigious Golda Meir Fellowship Lectureship Award, 2020.